HIV Status and Contraceptive Utilization Among Women in Cameroon
Overview
Authors
Affiliations
Objective: We examined patterns of contraceptive utilization by HIV status among women in Cameroon, hypothesizing that women living with HIV would utilize contraception at higher rates than their HIV-negative peers.
Methods: Deidentified, clinical data from the Cameroon Baptist Convention Health Services (2007-2013) were analyzed (N = 8995). Frequencies compared outcomes between women living with HIV (15.1%) and uninfected women. Multivariate analyses examined associates of contraceptive utilization and desire to become pregnant.
Results: Contraceptive utilization was associated with higher education, living with HIV, monogamy, and higher parity ( P < .001). Women living with HIV had 66% higher odds of using contraceptives than their negative peers (odds ratio [OR]: 1.66, confidence interval [CI]: 1.45-1.91, P < .001). Polygamous women had 37% lower odds of using contraceptives compared to monogamous women (OR: 0.63, 95% CI: 0.52-0.75, P < .001).
Conclusion: Increasing contraceptive utilization in resource-constrained settings should be a priority for clinicians and researchers. Doing so could improve population health by reducing HIV transmission between partners and from mother to child.
Structural barriers to maternity care in Cameroon: a qualitative study.
Harsono A, Bond C, Enah C, Ngong M, Kyeng R, Wallace E Reprod Health. 2024; 21(1):108.
PMID: 39030544 PMC: 11264682. DOI: 10.1186/s12978-024-01834-w.
Winters A, Jakeman B, Aragon K, Kasten Z, Bos A, Snyder J J Int Assoc Provid AIDS Care. 2022; 21:23259582221144449.
PMID: 36536987 PMC: 9772939. DOI: 10.1177/23259582221144449.
Lee J, Gutin S, Getahun M, Okiring J, Neilands T, Akullian A Contraception. 2022; 117:13-21.
PMID: 36115610 PMC: 9984206. DOI: 10.1016/j.contraception.2022.09.001.
Budhwani H, Enah C, Bond C, Halle-Ekane G, Wallace E, Turan J Int J Womens Health. 2022; 14:677-686.
PMID: 35572348 PMC: 9093609. DOI: 10.2147/IJWH.S353919.
Low Rates of Contraception Use in Women With Human Immunodeficiency Virus.
Bhatta M, Bian A, Norwood J, Shepherd B, Ransby I, Nelson J Open Forum Infect Dis. 2022; 9(5):ofac113.
PMID: 35392458 PMC: 8982767. DOI: 10.1093/ofid/ofac113.